Oramed Pharmaceuticals Files Q1 2025 10-Q
Ticker: ORMP · Form: 10-Q · Filed: May 15, 2025 · CIK: 1176309
| Field | Detail |
|---|---|
| Company | Oramed Pharmaceuticals Inc. (ORMP) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, pharmaceuticals
TL;DR
Oramed Pharma filed its Q1 2025 10-Q. Check financials.
AI Summary
Oramed Pharmaceuticals Inc. filed its quarterly report on Form 10-Q for the period ended March 31, 2025. The company, incorporated in Delaware, is based in New York, NY, and operates in the pharmaceutical preparations industry. The filing details its financial performance and business operations for the quarter.
Why It Matters
This filing provides investors and analysts with the latest financial and operational data for Oramed Pharmaceuticals, crucial for understanding the company's current standing and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant new risks indicated.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's annual accounting period.)
- 98-0376008 — EIN (Employer Identification Number for tax purposes.)
Key Players & Entities
- ORAMED PHARMACEUTICALS INC. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- New York, NY (location) — Principal Executive Offices
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 001-35813 (company_id) — Commission file number
FAQ
What is the primary business of Oramed Pharmaceuticals Inc.?
Oramed Pharmaceuticals Inc. is primarily involved in the Pharmaceutical Preparations industry, as indicated by its Standard Industrial Classification code 2834.
For what period is this 10-Q filing?
This Form 10-Q is for the quarterly period ended March 31, 2025.
Where are Oramed Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices of Oramed Pharmaceuticals Inc. are located at 1185 Avenue of the Americas, Third Floor, New York, NY 10036.
What is the commission file number for Oramed Pharmaceuticals Inc.?
The commission file number for Oramed Pharmaceuticals Inc. is 001-35813.
In which U.S. state was Oramed Pharmaceuticals Inc. incorporated?
Oramed Pharmaceuticals Inc. was incorporated in Delaware.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding ORAMED PHARMACEUTICALS INC. (ORMP).